Skip to main content
. 2013 Jan 24;13:35. doi: 10.1186/1471-2334-13-35

Table 1.

Antimicrobial susceptibility of 65 Neisseria gonorrhoeae isolates from India (n=40), Pakistan (n=18), and Bhutan (n=7) in 2007–2011

Antimicrobial Breakpoints (susceptible/resistant, mg/L) MIC range (mg/L) Resistant, number (%) Intermediate susceptible, number (%) Susceptible, number (%)
Ciprofloxacin
S≤0.03/R>0.06a
0.064->32
61 (93.8)
4 (6.2)
0 (0)
Penicillin Gb
S≤0.06/R>1a
0.016->32
44 (67.7)
20 (30.8)
1 (1.5)
Erythromycinc
S≤0.25/R>0.5c
0.032-128
40 (61.5)
8 (12.3)
17 (26.2)
Tetracycline
S≤0.5/R>1a
0.125-64
36 (55.4)
22 (33.8)
7 (10.8)
Azithromycin
S≤0.25/R>0.5a
0.016-4
5 (7.7)
10 (15.4)
50 (76.9)
Spectinomycin
S≤64/R>64a
4-16
0 (0)
0 (0)
65 (100)
Ceftriaxone
S≤0.12/R>0.12a
<0.002-0.064
0 (0)
0 (0)
65 (100)
Cefixime S≤0.12/R>0.12a <0.016-0.064 0 (0) 0 (0) 65 (100)

aBreakpoints according to The European Committee on Antimicrobial Susceptibility Testing. (EUCAST (http://www.eucast.org; Clinical breakpoints v2.0)).

bβ-lactamase was produced by 34 (52%) of the examined isolates, and all these isolates were considered as resistant to penicillin G independent on their MIC values.

cBecause of the lack of EUCAST breakpoints, the EUCAST breakpoints for azithromycin were used also for erythromycin.

MIC, minimum inhibitory concentration.